These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 12139457)

  • 1. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
    Caravan P; Parigi G; Chasse JM; Cloutier NJ; Ellison JJ; Lauffer RB; Luchinat C; McDermid SA; Spiller M; McMurry TJ
    Inorg Chem; 2007 Aug; 46(16):6632-9. PubMed ID: 17625839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Characterization, and Biodistribution of a Dinuclear Gadolinium Complex with Improved Properties as a Blood Pool MRI Agent.
    La Cava F; Fringuello Mingo A; Miragoli L; Terreno E; Cappelletti E; Lattuada L; Poggi L; Colombo Serra S
    ChemMedChem; 2018 Apr; 13(8):824-834. PubMed ID: 29442438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural, kinetic, and thermodynamic characterization of the interconverting isomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.
    Tyeklar Z; Dunham SU; Midelfort K; Scott DM; Sajiki H; Ong K; Lauffer RB; Caravan P; McMurry TJ
    Inorg Chem; 2007 Aug; 46(16):6621-31. PubMed ID: 17625838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
    Laurent S; Elst LV; Muller RN
    Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
    Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
    Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.
    Caravan P; Cloutier NJ; Greenfield MT; McDermid SA; Dunham SU; Bulte JW; Amedio JC; Looby RJ; Supkowski RM; Horrocks WD; McMurry TJ; Lauffer RB
    J Am Chem Soc; 2002 Mar; 124(12):3152-62. PubMed ID: 11902904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.
    Raghunand N; Jagadish B; Trouard TP; Galons JP; Gillies RJ; Mash EA
    Magn Reson Med; 2006 Jun; 55(6):1272-80. PubMed ID: 16700014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of halide salts influences the non-covalent interaction of MRI contrast agents and human serum albumin.
    Henrotte V; Muller RN; Bartholet A; Elst LV
    Contrast Media Mol Imaging; 2007; 2(5):258-61. PubMed ID: 18058865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
    Martin VV; Ralston WH; Hynes MR; Keana JF
    Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
    Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-ionic bulky Gd(III) DTPA-bisamide complexes as potential contrast agents for magnetic resonance imaging.
    Bligh SW; Chowdhury AH; Kennedy D; Luchinat C; Parigi G
    Magn Reson Med; 1999 Apr; 41(4):767-73. PubMed ID: 10332853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.